This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Allgenesis Biotherapeutics Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Shu Chieh Yu: Innovator in Pharmaceutical Compounds
Introduction
Shu Chieh Yu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as BACE1 inhibitors. His work aims to address various cognitive disorders and diseases.
Latest Patents
Shu Chieh Yu holds a patent for "Compounds and their use as BACE1 inhibitors." This invention relates to specific compounds of Formula (I) or their stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates. The patent outlines a pharmaceutical composition that includes these compounds and describes therapeutic methods for treating and preventing conditions such as Down syndrome, Alzheimer's disease, and other neurodegenerative disorders.
Career Highlights
Yu is currently associated with Allgenesis Biotherapeutics Inc., where he continues to innovate in the pharmaceutical sector. His research focuses on developing effective treatments for cognitive impairments and related diseases.
Collaborations
Shu Chieh Yu has worked alongside notable colleagues such as Thomas Malone and Yesudoss Christu Rajan. Their collaborative efforts contribute to advancing research in the field of biotherapeutics.
Conclusion
Shu Chieh Yu's work in developing BACE1 inhibitors represents a significant advancement in the treatment of cognitive disorders. His contributions to the pharmaceutical industry highlight the importance of innovation in addressing complex health challenges.